KASINGER JAMES R. (General Counsel and Secretary) sold 3.6% of their position (3.45K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $166.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2026ACC: 0001193125-26-111281
Officer· General Counsel and Secretary
Since Feb 2026
-3.45K
Net shares
Net seller
$166.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.88K acquired · 10.32K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+6.88K
Price / share
—
Trade value
—
% of position
7.8%
3/14/2026
87.81K→94.69K
Common Shares
Direct
Shares
−3.45K
Price / share
$48.26
Trade value
$166.50K
% of position
3.6%
3/16/2026
94.69K→91.24K
Total
Net shares
+3.42K
Net value
-$166.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/14/2026 | M · Option Exercise | +6.88K | — | — | 7.8% | 87.81K | 94.69K |
| Common Shares Direct | 3/16/2026 | S · Sale | −3.45K | $48.26 | $166.50K | 3.6% | 94.69K | 91.24K |
| Total | +3.42K | -$166.50K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
6.88K shares
Shares
−6.88K
Strike price
Held after
20.63K
Exercisable
—
3/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares6.88K shares | 3/14/2026 | M · Option Exercise | −6.88K | — | 20.63K |